EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Managing Neonatal Pulmonary Hypertension in Low‐Resource Settings

R Kishore Kumar iD, Ju-Lee Oei, Rajeshwari Madappa, Satyan Lakshminrusimha iD

Journal of Paediatrics and Child Health · 2026

DOI: 10.1111/jpc.70550 ↗

At a glance

Übersichtsarbeit in Journal of Paediatrics and Child Health, 2026. Written by R Kishore Kumar and 3 co-authors. Institution: Department of Neonatology & Paediatrics, Cloudnine Hospital, Bangalore, Karnataka, India. Major MEDLINE topics: Vasodilator Agents, Nitric Oxide, Persistent Fetal Circulation Syndrome, Hypertension, Pulmonary. 90 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Persistent pulmonary hypertension of the newborn (PPHN) is a critical condition marked by elevated pulmonary vascular resistance (PVR) and persistent hypoxemia, due to the failure of transition from foetal to neonatal circulation. Management focuses on reducing PVR, enhancing pulmonary vasodilation, and ensuring adequate oxygen delivery. Inhaled nitric oxide (iNO), an FDA‐approved therapy, effectively lowers PVR and improves oxygenation in term neonates. However, in resource‐limited settings, its use is constrained by high costs, the need for specialized equipment, and limited availability of medical‐grade iNO, with industrial‐grade NO sometimes used despite potential impurities. These limitations have led to increased use of accessible alternatives such as sildenafil, milrinone and other vasodilators, which offer vital options where iNO is not feasible. This review highlights regional variability in management, the impact of resource constraints, and the need for equitable care. Using India as an example, a 10‐step approach for managing PPHN in low‐resource settings is proposed, alongside a call for standardized protocols and further research into both established and emerging therapies.

Subjects

MeSH terms (MEDLINE)

Vasodilator AgentsNitric OxidePersistent Fetal Circulation SyndromeHypertension, PulmonaryHumansResource-Limited SettingsInfant, NewbornIndiaMilrinoneSildenafil CitrateAdministration, Inhalation

Author keywords

health services accessibilityinfantmilrinonenewbornnitric oxidepersistent foetal circulation syndromepulmonary hypertensionsildenafil citrate

Substances

Vasodilator AgentsNitric OxideMilrinoneSildenafil Citrate

Authors and institutions

  • Department of Neonatology & Paediatrics, Cloudnine Hospital, Bangalore, Karnataka, India.
  • Department of Neonatology, Notre Dame University, Perth, Australia.
  • Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.
  • Department of Neonatology, Mater Mother's Hospital, Brisbane, Queensland, Australia.
  • Department of Pediatrics, Sigma Hospital, Mysuru, Karnataka, India.
  • Department of Pediatrics, UC Davis Children's Hospital, Sacramento, California, USA.

ORCID profiles: R Kishore Kumar, Satyan Lakshminrusimha

Cite

APA

Kumar, R. K., Oei, J. L., Madappa, R., & Lakshminrusimha, S. (2026). Managing Neonatal Pulmonary Hypertension in Low‐Resource Settings. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70550

Vancouver

Kumar RK, Oei JL, Madappa R, Lakshminrusimha S. Managing Neonatal Pulmonary Hypertension in Low‐Resource Settings. Journal of Paediatrics and Child Health. 2026. doi:10.1111/jpc.70550

BibTeX
@article{Kumar2026,
  author = {Kumar, R Kishore and Oei, Ju-Lee and Madappa, Rajeshwari and Lakshminrusimha, Satyan},
  title = {Managing Neonatal Pulmonary Hypertension in Low‐Resource Settings},
  journal = {Journal of Paediatrics and Child Health},
  year = {2026},
  doi = {10.1111/jpc.70550}
}
Start for free →